HAEMONETICS CORP — Director's Dealing 2018

Jan 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-01-02

Reporting Person: KROLL MARK W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-02	Common Stock	M	7118	$34.405	Acquired	33881	Direct
2018-01-02	Common Stock	S	7118	$63.00	Disposed	26763	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-02	Non-qualified Stock Option (Right to Buy)	$34.405	M	7118	Disposed	2018-07-21	Common Stock (7118)	Direct

Footnotes

F1: Exercise and sale pursuant to a trading plan which was established consistent with the requirements of Rule 10b5-1.

F2: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.